ASHPOfficial

In this episode, the team from The Ohio State University Wexner Medical Center discusses their award-winning ASHP Best Practices submission. They share how the program leveraged the unique expertise of pharmacist informaticists to take advantage of EHR and build tools to automate the selection of preferred biosimilar, iron and Biosimilars, Iron, and 505(b)(2) products based on the patient's insurance and hospital formulary preferences and time to payor approval for patients, reduced the administrative burden of the PA process, and improved the quality of our patient care. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP’s education director, Hannah Post is joined by Angela Cassano, president of Pharmfusion Consulting, LLC, William Hammonds, clinical pharmacy manager at West Virginia University Medicine, and Carrington Huneycutt, director of clinical pharmacy at Tandem Health, South Carolina, as they discuss their upcoming Midyear session that focuses on implementation and evolution of clinical pharmacy technician roles. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Pharmacists providing care to patients following toxicologic ingestions of medications and other substances are often relied upon for treatment and monitoring recommendations. Many pharmacists do not routinely care for patients following toxicologic ingestions of medications or other substances and are unfamiliar with clinical presentation of various toxidromes and ultimately management strategies. This episode covers anticholinergic, cholinergic, sedative-hypnotic, opioid, sympathomimetic, serotonin syndrome, neuroleptic malignant syndrome, and malignant hypethermia toxidromes and discusses the clinical presentation and causative medications/substances and general treatment approaches, with an emphasis on antidotes for specific toxidromes including physostigmine, naloxone, flumazenil, atropine, and pralidoxime. CE expires two years from when this episode was originally published. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode, we dive into the essentials of beyond-use dating (BUD) in sterile compounding. What exactly is a BUD, and how does it differ from a manufacturer’s expiration date? We’ll break it down, explore key insights from USP <797>, and highlight what every sterile compounder needs to know. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Charrai Byrd, director of pharmacy services at New York-Presbyterian Hospital, as he shares what drew him to a career in pharmacy. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast explores unique opportunities for pharmacists to pursue a Fulbright Scholar Award, highlighting pathways for academic exchange, research, and global health collaboration. Featuring insights from a recent Fulbright recipient, the discussion covers how pharmacists can contribute to and benefit from international scholarship and cultural diplomacy. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP’s senior education director, Cindy Von Heeringen is joined by James Hoffman, senior vice president of quality and safety, member, pharmacy and pharmaceutical sciences at St. Jude Children's Research Hospital, and Joe DiPiro, professor emeritus at Virginia Commonwealth University, School of Pharmacy, as they discuss their upcoming Midyear session that focuses on relevant trends in the external environment that will have a major impact on health-system pharmacy practice over the next five years. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This episode discusses the remainder of the results of the work from home survey conducted in 2024 by members of the Section of Specialty Pharmacy Practitioners Advisory Group on Operational and Workforce Development. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP’s senior education director, Cindy Von Heeringen is joined by Tyler Vest, network director of pharmacy, pharmacy supply chain at the University of Vermont Health Network, as he discusses his upcoming Midyear sessions that focus on ongoing research about the medication use process and the current state. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast provides a review of newer over-the-counter (OTC) items related to pharmacy practice. Participants discuss OTC CGMs, naloxone, birth control, combined influenza/COVID home tests and STD/syphilis home tests. The episode highlights cost information, where to purchase, how and when to use, and more. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast, members of the Pharmacy Administration and Leadership Residents’ Collaborative explore disruptive innovations with Dr. Nishaminy Kasbekar and consider future implications as we work to expand medication access. Speakers discuss how these changes are transforming drug procurement, addressing challenges like drug shortages, and improving medication affordability for patients. Dr. Kasbekar also shares insights on how models like those adopted at her own institution could shape the future of pharmacy practice across health systems nationwide. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP’s senior education director, Cindy von Heeringen is joined by Mitchell Buckley, clinical pharmacy specialist at Buckley Group Enterprises LLC, as he discusses his upcoming Midyear sessions that focus on acute care clinical pharmacy performance metrics and the unique pharmacokinetic and pharmacodynamic challenges in dosing chemotherapy, anticoagulants, and antimicrobials for obese and underweight patients. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In anticipation of the 2025 ASHP Conference for Pharmacy Leaders, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP, as she interviews John Clark, associate chief pharmacy officer at Michigan Medicine Health and clinical associate professor at the University of Michigan College of Pharmacy, and Tara Vlasimsky, system director of ambulatory pharmacy for Intermountain Health, as they discuss their upcoming session From Strategy to Execution for Agile Organizations. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Join us for a conversation with Cheryl Wisseh and Ryan Larson, ASHP Foundation grantees, who will discuss their research, implications for practice, and improving the health of patients and communities. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The American Foundation for Suicide Prevention (AFSP) is a voluntary health organization that gives those affected by suicide a nationwide community empowered by research, education, and advocacy to take action against this leading cause of death. With local programs and events in all 50 states, AFSP’s chapters are at the forefront of suicide prevention. This podcast will highlight the impact of change, specifically major life transitions, on mental health and suicide risk, as well as how members can address these challenges to promote positive well-being. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In anticipation of the 2025 ASHP Conference for Pharmacy Leaders, ASHP is hosting a series of podcast episodes. Join our host, Cynthia Von Heeringen, senior education director at ASHP as she interviews Kathryn Brown, senior vice president and chief operating officer for national pharmacy at Kaiser Permanente and Elizabeth Rebo, executive director of medication safety at Kaiser Permanente, as they discuss their upcoming sessions Embracing Innovation in Patient Care Services: Demonstrating Value Using Digital Tools, AI, and Integrated Technologies & Change Management in a Season with Generative AI. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this episode Kim Benner and Lauren Ashton discuss their experiences in the ASHP Guided Mentorship Program. They share how mentorship has shaped their professional growth, how the success of a Student Society of Health-System Pharmacy initiative implemented at Lauren’s school, and offer valuable advice for future mentor-mentee pairs. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Patients with opioid use disorder (OUD) present to the hospital setting for a variety of reasons, so emergency and inpatient pharmacists increasingly need to have a working knowledge of OUD, its treatment modalities, and other factors that affect the management of these patients. This podcast will discuss aspects of care from presentation to discharge, dispel common misconceptions about the management of OUD and acute pain, and promote a standardized approach to care of an often-marginalized population of patients. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This is the final episode in a three-part series unveiling how pharmacy technology change requests are taken from idea to implementation. This podcast discusses the next steps required for build validation, testing, implementation, and post-implementation. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Discover the essential contributions of pharmacists in patient care with We’re Your Pharmacist, a monthly podcast from ASHP. This episode features Joseph Marchiano, lead clinical pharmacist in geriatrics at Summa Health System and assistant professor of pharmacy practice at Northeast Ohio Medical University, as he shares what drew him to a career in pharmacy. Gain insights into the diverse opportunities within the pharmacy profession and learn how pharmacists are making a difference every day. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.